Clinical Trial Update: Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark) [NA]

View source ↗

Summary

Clinical trial update reporting a completed study evaluating the re-volumizing performance of Aliaxin for malar and sub-malar volume deficiency. The sponsor is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malar and Sub-malar Volume Deficiency

Drugs mentioned

• Aliaxin

Snippet

Sponsor: Derming SRL | Conditions: Malar and Sub-malar Volume Deficiency | NA | Status: COMPLETED